This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of California. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: Teruaki Nakatsuji: Innovator in Cancer Treatment
Introduction
Teruaki Nakatsuji is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment, holding a total of 8 patents. His work focuses on developing methods and compositions that address skin damage and microbial infections.
Latest Patents
Among his latest patents, Nakatsuji has developed compositions and methods for treating cancer. One notable patent describes methods and compositions for preventing skin damage due to UV radiation. This method includes contacting the skin with an effective amount of a composition containing specific compounds. Another patent focuses on antimicrobial therapy, providing methods and compositions that utilize hogocidin peptides, derivatives, and variants. These innovations also include probiotic compositions that utilize strains producing hogocidin or other inhibitors of skin pathogens. Additionally, methods for treating microbial skin infections and atopic dermatitis are part of his contributions.
Career Highlights
Teruaki Nakatsuji is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its potential impact on skin health and cancer treatment.
Collaborations
His notable coworker, Richard L Gallo, has collaborated with Nakatsuji on various research projects, further enhancing the scope of their work in dermatological innovations.
Conclusion
Teruaki Nakatsuji's innovative contributions to cancer treatment and skin health exemplify the importance of research in improving medical outcomes. His patents reflect a commitment to addressing significant health challenges through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
